HLA-DPB1*0202 Is Associated with a Predictor of Good Prognosis of Graves' Disease in the Japanese

Human Immunology

Volumn 67, Issue 1-2, 2006, Pages 47-52

  Takahashi, Megumi ^a   Yasunami, Michio ^a   Kubota, Sumihisa ^b   Tamai, Hajime ^b   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Association study; Graves' disease; HLA A; HLA DP; Predictor of prognosis

Indexed keywords

HLA A ANTIGEN; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; THYROID STIMULATING IMMUNOGLOBULIN; UNCLASSIFIED DRUG; AUTOANTIBODY; HLA DPB1*0202; HLA-DPB1*0202; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN;

ALLELE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GRAVES DISEASE; HUMAN; IMMUNOGENETICS; JAPAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; BLOOD; GENETIC MARKER; GENETICS;

ALLELES; AUTOANTIBODIES; GENETIC MARKERS; GRAVES DISEASE; HLA-DP ANTIGENS; HUMANS; JAPAN; PROGNOSIS; RECEPTORS, THYROTROPIN;

EID: 33646379625     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.023     Document Type: Article

References (34)

1. Boehm B.O., Kuhnl P., Manfras B.J., Chen M., Lee J.C., Holzberger G., Seidl S., Schifferdecker E., Schumm-Draeger P.M., and Usadel K.H. HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Clin Invest 70 (1992) 956
2. Maciel L.M., Rodrigues S.S., Dibbern R.S., Navarro P.A., and Donadi E.A. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11 (2001) 31
3. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Kok C.C., French M., Mallal S., and Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167 (1999) 257
4. Cheong K.Y., Allcock R.J., Eerligh P., Witt C.S., Christiansen F.T., McCann V., and Price P. Localization of central MHC genes influencing type I diabetes. Hum Immunol 62 (2001) 1363
5. Cecere A., Tancredi L., and Gattoni A. Primary sclerosing cholangitis. Panminerva Med 44 (2002) 313
6. Donmez B., Ozakbas S., Oktem M.A., Gedizlioglu M., Coker I., Genc A., and Idiman E. HLA genotypes in Turkish patients with myasthenia gravis. comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum Immunol 65 (2004) 752
7. Wirtz P.W., Willcox N., van der Slik A.R., Lang B., Maddison P., Koeleman B.P., Giphart M.J., Wintzen A.R., Roep B.O., and Verschuuren J.J. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol 159 (2005) 230
8. Dong R.P., Kimura A., Okubo R., Shinagawa H., Tamai H., Nishimura Y., and Sasazuki T. HLA and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 35 (1992) 165
9. Zakarija M., and McKenzie J.M. Thyroid-stimulating antibody (TSAb) of Graves' disease. Life Sci 32 (1983) 31
10. Mukuta T., Tamai H., Oshima A., Morita T., Matsubayashi S., Fukata S., and Kuma K. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin. Clin Endocrinol 40 (1994) 215
11. Kawai K., Tamai H., Mori T., Morita T., Matsubayashi S., Katayama S., Kuma K., and Kumagai L.F. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 77 (1993) 716
12. Bunce M., Franning G.L., and Welsh K.I. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 45 (1995) 81
13. Sengar D.P., Hampton N., Goldstein R., and Sengar A.S. Comprehensive typing of HLA-DPB1 allele by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Clin Invest Med 18 (1995) 465
14. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251
15. Haldane J.B.S. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20 (1955) 309
16. Park M.H., Park J.P., Song E.Y., Park H., Kim T.Y., Park D.J., Park K.S., and Cho B.Y. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 66 (2005) 741
17. Huang S.M., Wu T.J., Lee T.D., Yang E.K., Shaw C.K., and The C.C. The association of HLA-A, -B, and -DRB1 genotypes with Graves disease in Taiwanese people. Tissue Antigens 61 (2003) 154
18. Tomer Y., and Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes. from gene mapping to gene function. Endocr Rev 24 (2003) 694
19. Yanagawa T., Hidaka Y., Guimaraes V., Soliman M., and DeGroot L.J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80 (1995) 41
20. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tirgoviste C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., and Gough S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506
21. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator. design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149
22. Corda D., Bizzarri C., Di Girolamo M., Valitutti S., and Luini A. G protein-linked receptors in the thyroid. Adv Exp Med Biol 261 (1989) 245
23. Nagayama Y., Namba H., Yokoyama N., Yamashita S., and Niwa M. Role of asparagine-linked oligosaccharides in protein folding, membrane targeting, and thyrotropin and autoantibody binding of human thyrotropin receptor. J Biol Chem 273 (1998) 33423
24. Ochi Y., Kajita Y., Hamazu M., and Nagata A. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Hormone Res 59 (2003) 222
25. Kawai K., Tamai H., Matsubayashi S., Mukuta T., Morita T., Kubo C., and Kuma K. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs. Clin Endocrinol 43 (1995) 551
26. Sawai Y., and DeGroot L.J. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 85 (1999) 1176
27. Salamon H., Klitz W., Easteal S., Gao X., Erlich H.A., Fernandez-Vina M., Trachtenberg E.A., McWeeney S.K., Nelson M.P., and Thomson G. Evolution of HLA class II molecules. allelic and amino acid site variability across populations. Genetics 152 (1999) 393
28. Volpe R. Immunoregulation in autoimmune thyroid disease. Thyroid 4 (1994) 373
29. Sidney J., del Guercio M.F., Southwood S., Hermanson G., Maewal A., Appella E., and Sette A. The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire. Hum Immunol 58 (1997) 12
30. Ressing M.E., de Jong J.H., Brandt R.M.P., Drijfhout J.W., Benckhuijsen W.E., Schreuder G.M.T., Offringa R., Kast W.M., and Melief C.J.M. Differential binding of viral peptides to HLA-A2 alleles. implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma. Eur J Immunol 29 (1999) 1292
31. Sudo T., Kamikawaji N., Kimura A., Date Y., Savoie C.J., Nakashima H., Furuichi E., Kuhara S., and Sasazuki T. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 155 (1995) 4749
32. Wan X.L., Kimura A., Dong R.P., Honda K., Tamai H., and Sasazuki T. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol 42 (1995) 131
33. Nakanishi K., Kobayashi T., Murase T., Nakatsuji T., Inoko H., Tsuji K., and Kosaka K. Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes 42 (1993) 1086
34. Hamaguchi K., Kimura A., Seki N., Higuchi T., Yasunaga S., Takahashi M., Sasazuki T., Kusuda Y., Okeda T., Itoh K., and Sakata T. Analysis of tumor necrosis factor-α promoter polymorphism in type 1 diabetes. HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55 (2000) 10